Literature DB >> 2193292

Tumour-related expression of a translation-elongation factor-like protein.

I Koch1, P H Hofschneider, F Lottspeich, C Eckerskorn, R Koshy.   

Abstract

We have identified a tumour-related 43 kd cytoplasmic protein (LC/p43) using a monoclonal antibody against the total proteins of human hepatoma cell line PLC/PRF/5. LC/p43 is preferentially expressed in a variety of tumours of human and animal origin, whereas no expression was detected in several normal adult tissues tested. LC/p43 expression was induced in rodent fibroblasts upon transfection with several viral oncogenes. Expression in non-transformed peripheral blood lymphocytes could be induced by treatment with phytohaemagglutinin (PHA) and subsequent culture with interleukin II, whereas retinoic acid treatment of transformed cells caused a drastic reduction of the antigen in the cells. Sequence analysis of three tryptic peptides of LC/p43 revealed 50-70% homology to different domains of the eukaryotic and prokaryotic translation-elongation factors EF1-alpha and EF-Tu, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193292

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  Constitutive modulation of Raf-1 protein kinase is associated with differential gene expression of several known and unknown genes.

Authors:  S Patel; F H Wang; T L Whiteside; U Kasid
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

2.  Expression of elongation factor (EF)-Tu is correlated with prognosis of gastric adenocarcinomas.

Authors:  Chaoyang Xu; Jianjun Wang; Jiajia Li; Rengui Fang
Journal:  Int J Mol Sci       Date:  2011-10-10       Impact factor: 5.923

3.  Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.

Authors:  King-Wah Chiu; Toshiaki Nakano; Kuang-Den Chen; Li-Wen Hsu; Chia-Yun Lai; Ching-Yin Huang; Yu-Fan Cheng; Shigeru Goto; Chao-Long Chen
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.